You searched for "respiratory"
In conversation with Nick Jones
“I admit to having felt vulnerable and anxious about exposing my work to scrutiny, and I still do.” From nasal reconstruction to poetry composition: retired rhinologist, Nick Jones - author of new poetry collection, Encounter - tells us more about...
Lost and sound: exploring hyperbaric oxygen therapy for refractory SSNHL
Can hyperbaric oxygen therapy (HBOT) offer a breakthrough for patients with refractory sudden sensorineural hearing loss (SSNHL)? SSNHL is defined as acute hearing loss of ≥30 decibels in three consecutive frequencies within three days. Typically, it’s treated with two weeks...Government Guidance on Hearing Aids
The UK Government’s Department of Health and Social Care (DHSC) has announced that tens of thousands of people with hearing loss will have access to new hearing aid devices, thanks to fresh guidance allowing businesses around the world to sell certain pioneering hearing aids in the UK.Anaesthesia under fire
Kate Prior is an anaesthetist who has, quite literally, been there, done that. In this article she manages to use words on a page to bring to life some of the conditions and challenges she faced as a member of...Addressing the hearing needs of people with dementia
Dr Dawes provides a comprehensive overview of hearing needs of persons with dementia coupled with recommended guidelines for hearing-related considerations when assessing and intervening with persons with dementia. With ageing populations, we face a global dementia challenge. Rates of both...
Multisystem pathology in refractory otitis media with effusion
Recurrent middle ear effusion is a common problem and so is rhinosinusitis with polyposis. It is not often thought that the problem could be linked to multisystem pathology, such as eosinophilic granulomatous with polyposis. Therefore, repeated grommet insertions and surgical...
Long-term results for dupilumab are very promising!
Eosinophilic chronic rhinosinusitis (eCRS) is complicated by frequent early and aggressive recurrence of polyps after both medical and surgical treatment regimes. Dupilumab is an anti-IL-4/IL-3 receptor monoclonal antibody and has been previously studied in the SINUS-52 study, with an observation...
